IGG practice guidelines on germ cell tumor in adult male patients

Ugo De Giorgi, Nicola Nicolai, Silvia Tana, Ivan Matteo Tavolini, Silvia Palazzi, Sergio Bracarda, Lucilla Tedeschi, Giovannella Palmieri, Luca Frassineti, Luigi Da Pozzo, Ugo Pastorino, Ermanno Emiliani, Maurizio Marangolo, Giorgio Pizzocaro, Giovanni Rosti, Roberto Salvioni

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Germ cell tumors are rare neoplasms that affect young males. Nearly 99% of patients with localized stage I disease and nearly 80% of patients with metastatic disease can be cured. Even patients who relapse following chemotherapy can achieve a long-term survival in approximately 30-40% of cases. The main objective in early stages and in good prognosis patients has changed in recent years, and it has become of major importance to reduce treatment-related morbidity without compromising the excellent long-term survival rate. In poor prognosis patients, there is a correlation between the experience of the treating institution and the long-term clinical outcome of the patients, particularly when the most sophisticated therapies are needed. So far, of utmost importance is the information from updated practice guidelines for the diagnosis and treatment of germ cell tumors. The Italian Germ cell cancer Group (IGG) has developed the following clinical recommendations, which identify me current standards in diagnosis and treatment of germ cell tumors in adult males.

Original languageEnglish
Pages (from-to)96-109
Number of pages14
JournalTumori
Volume94
Issue number1
Publication statusPublished - Jan 2008

Fingerprint

Germ Cell and Embryonal Neoplasms
Practice Guidelines
Therapeutics
Survival Rate
Morbidity
Recurrence
Drug Therapy
Survival
Neoplasms

Keywords

  • Germ cell tumor
  • Guidelines
  • Non-seminoma
  • Seminoma
  • Testicular cancer

ASJC Scopus subject areas

  • Cancer Research

Cite this

De Giorgi, U., Nicolai, N., Tana, S., Tavolini, I. M., Palazzi, S., Bracarda, S., ... Salvioni, R. (2008). IGG practice guidelines on germ cell tumor in adult male patients. Tumori, 94(1), 96-109.

IGG practice guidelines on germ cell tumor in adult male patients. / De Giorgi, Ugo; Nicolai, Nicola; Tana, Silvia; Tavolini, Ivan Matteo; Palazzi, Silvia; Bracarda, Sergio; Tedeschi, Lucilla; Palmieri, Giovannella; Frassineti, Luca; Da Pozzo, Luigi; Pastorino, Ugo; Emiliani, Ermanno; Marangolo, Maurizio; Pizzocaro, Giorgio; Rosti, Giovanni; Salvioni, Roberto.

In: Tumori, Vol. 94, No. 1, 01.2008, p. 96-109.

Research output: Contribution to journalArticle

De Giorgi, U, Nicolai, N, Tana, S, Tavolini, IM, Palazzi, S, Bracarda, S, Tedeschi, L, Palmieri, G, Frassineti, L, Da Pozzo, L, Pastorino, U, Emiliani, E, Marangolo, M, Pizzocaro, G, Rosti, G & Salvioni, R 2008, 'IGG practice guidelines on germ cell tumor in adult male patients', Tumori, vol. 94, no. 1, pp. 96-109.
De Giorgi U, Nicolai N, Tana S, Tavolini IM, Palazzi S, Bracarda S et al. IGG practice guidelines on germ cell tumor in adult male patients. Tumori. 2008 Jan;94(1):96-109.
De Giorgi, Ugo ; Nicolai, Nicola ; Tana, Silvia ; Tavolini, Ivan Matteo ; Palazzi, Silvia ; Bracarda, Sergio ; Tedeschi, Lucilla ; Palmieri, Giovannella ; Frassineti, Luca ; Da Pozzo, Luigi ; Pastorino, Ugo ; Emiliani, Ermanno ; Marangolo, Maurizio ; Pizzocaro, Giorgio ; Rosti, Giovanni ; Salvioni, Roberto. / IGG practice guidelines on germ cell tumor in adult male patients. In: Tumori. 2008 ; Vol. 94, No. 1. pp. 96-109.
@article{f6747edc194e472ca0ae0c1805f02a22,
title = "IGG practice guidelines on germ cell tumor in adult male patients",
abstract = "Germ cell tumors are rare neoplasms that affect young males. Nearly 99{\%} of patients with localized stage I disease and nearly 80{\%} of patients with metastatic disease can be cured. Even patients who relapse following chemotherapy can achieve a long-term survival in approximately 30-40{\%} of cases. The main objective in early stages and in good prognosis patients has changed in recent years, and it has become of major importance to reduce treatment-related morbidity without compromising the excellent long-term survival rate. In poor prognosis patients, there is a correlation between the experience of the treating institution and the long-term clinical outcome of the patients, particularly when the most sophisticated therapies are needed. So far, of utmost importance is the information from updated practice guidelines for the diagnosis and treatment of germ cell tumors. The Italian Germ cell cancer Group (IGG) has developed the following clinical recommendations, which identify me current standards in diagnosis and treatment of germ cell tumors in adult males.",
keywords = "Germ cell tumor, Guidelines, Non-seminoma, Seminoma, Testicular cancer",
author = "{De Giorgi}, Ugo and Nicola Nicolai and Silvia Tana and Tavolini, {Ivan Matteo} and Silvia Palazzi and Sergio Bracarda and Lucilla Tedeschi and Giovannella Palmieri and Luca Frassineti and {Da Pozzo}, Luigi and Ugo Pastorino and Ermanno Emiliani and Maurizio Marangolo and Giorgio Pizzocaro and Giovanni Rosti and Roberto Salvioni",
year = "2008",
month = "1",
language = "English",
volume = "94",
pages = "96--109",
journal = "Tumori",
issn = "0300-8916",
publisher = "SAGE Publications Ltd",
number = "1",

}

TY - JOUR

T1 - IGG practice guidelines on germ cell tumor in adult male patients

AU - De Giorgi, Ugo

AU - Nicolai, Nicola

AU - Tana, Silvia

AU - Tavolini, Ivan Matteo

AU - Palazzi, Silvia

AU - Bracarda, Sergio

AU - Tedeschi, Lucilla

AU - Palmieri, Giovannella

AU - Frassineti, Luca

AU - Da Pozzo, Luigi

AU - Pastorino, Ugo

AU - Emiliani, Ermanno

AU - Marangolo, Maurizio

AU - Pizzocaro, Giorgio

AU - Rosti, Giovanni

AU - Salvioni, Roberto

PY - 2008/1

Y1 - 2008/1

N2 - Germ cell tumors are rare neoplasms that affect young males. Nearly 99% of patients with localized stage I disease and nearly 80% of patients with metastatic disease can be cured. Even patients who relapse following chemotherapy can achieve a long-term survival in approximately 30-40% of cases. The main objective in early stages and in good prognosis patients has changed in recent years, and it has become of major importance to reduce treatment-related morbidity without compromising the excellent long-term survival rate. In poor prognosis patients, there is a correlation between the experience of the treating institution and the long-term clinical outcome of the patients, particularly when the most sophisticated therapies are needed. So far, of utmost importance is the information from updated practice guidelines for the diagnosis and treatment of germ cell tumors. The Italian Germ cell cancer Group (IGG) has developed the following clinical recommendations, which identify me current standards in diagnosis and treatment of germ cell tumors in adult males.

AB - Germ cell tumors are rare neoplasms that affect young males. Nearly 99% of patients with localized stage I disease and nearly 80% of patients with metastatic disease can be cured. Even patients who relapse following chemotherapy can achieve a long-term survival in approximately 30-40% of cases. The main objective in early stages and in good prognosis patients has changed in recent years, and it has become of major importance to reduce treatment-related morbidity without compromising the excellent long-term survival rate. In poor prognosis patients, there is a correlation between the experience of the treating institution and the long-term clinical outcome of the patients, particularly when the most sophisticated therapies are needed. So far, of utmost importance is the information from updated practice guidelines for the diagnosis and treatment of germ cell tumors. The Italian Germ cell cancer Group (IGG) has developed the following clinical recommendations, which identify me current standards in diagnosis and treatment of germ cell tumors in adult males.

KW - Germ cell tumor

KW - Guidelines

KW - Non-seminoma

KW - Seminoma

KW - Testicular cancer

UR - http://www.scopus.com/inward/record.url?scp=41749123747&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41749123747&partnerID=8YFLogxK

M3 - Article

VL - 94

SP - 96

EP - 109

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 1

ER -